These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8962195)

  • 1. Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of mononuclear cells in rheumatoid arthritis.
    Dimitrijevic M; Bartlett RR
    Transplant Proc; 1996 Dec; 28(6):3086-7. PubMed ID: 8962195
    [No Abstract]   [Full Text] [Related]  

  • 2. Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of peripheral blood and synovial fluid mononuclear cells in rheumatoid arthritis.
    Dimitrijevic M; Bartlett RR
    Inflamm Res; 1996 Nov; 45(11):550-6. PubMed ID: 8951506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide--mechanisms independent of pyrimidine depletion.
    Korn T; Magnus T; Toyka K; Jung S
    J Leukoc Biol; 2004 Nov; 76(5):950-60. PubMed ID: 15328336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide.
    Ulrichs K; Kaitschick J; Bartlett R; Müller-Ruchholtz W
    Transplant Proc; 1992 Apr; 24(2):718-9. PubMed ID: 1566498
    [No Abstract]   [Full Text] [Related]  

  • 5. Presence of a population of CD20+, CD38- B lymphocytes with defective proliferative responsiveness in the synovial compartment of patients with rheumatoid arthritis.
    Reparon-Schuijt CC; van Esch WJ; van Kooten C; Ezendam NP; Levarht EW; Breedveld FC; Verweij CL
    Arthritis Rheum; 2001 Sep; 44(9):2029-37. PubMed ID: 11592364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A inhibits CD69 expression induced on synovial fluid and peripheral blood lymphocytes by interleukin 15.
    Ortiz AM; García-Vicuña R; Sancho D; Laffon A; Sánchez-Madrid F; González-Alvaro I
    J Rheumatol; 2000 Oct; 27(10):2329-38. PubMed ID: 11036825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leflunomide.
    Cannon GW; Kremer JM
    Rheum Dis Clin North Am; 2004 May; 30(2):295-309, vi. PubMed ID: 15172042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide for the treatment of rheumatoid arthritis.
    Miceli-Richard C; Dougados M
    Expert Opin Pharmacother; 2003 Jun; 4(6):987-97. PubMed ID: 12783594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of synovial fluid on lymphocyte functions in rheumatoid arthritis.
    Dolganiuc A; Stavaru C; Radu DL; Olinescu A
    Roum Arch Microbiol Immunol; 1998; 57(3-4):243-54. PubMed ID: 11845436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of human peripheral blood mononuclear cell activation by the combination of leflunomide and pentoxifylline.
    Stojic Vukanic Z; Dimitrijevic M; Colic M; Popovic P; Jandric D
    Transplant Proc; 2001 May; 33(3):2137-8. PubMed ID: 11377478
    [No Abstract]   [Full Text] [Related]  

  • 12. Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis.
    Reddy SV; Wanchu A; Khullar M; Govindrajan S; Bambery P
    Int Immunopharmacol; 2005 Jun; 5(6):1085-90. PubMed ID: 15829424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial fluid transforming growth factor beta inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis.
    Summers KL; O'Donnell JL; Heiser A; Highton J; Hart DN
    Arthritis Rheum; 1999 Mar; 42(3):507-18. PubMed ID: 10088774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
    Kraan MC; Reece RJ; Barg EC; Smeets TJ; Farnell J; Rosenburg R; Veale DJ; Breedveld FC; Emery P; Tak PP
    Arthritis Rheum; 2000 Aug; 43(8):1820-30. PubMed ID: 10943872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel immunomodulating agent--leflunomide inhibits experimental autoimmune diabetes in mice.
    Stosić-Grujicić S; Dimitrijević M; Bartlett RR
    Transplant Proc; 1996 Dec; 28(6):3072-3. PubMed ID: 8962189
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2.
    Cao WW; Kao PN; Aoki Y; Xu JC; Shorthouse RA; Morris RE
    Transplant Proc; 1996 Dec; 28(6):3079-80. PubMed ID: 8962191
    [No Abstract]   [Full Text] [Related]  

  • 17. Recognition of cell surface GD3 by monoclonal antibody anti-6C2 in rheumatoid arthritis synovial fluid: expression on human T cells with transendothelial migratory activity.
    Homma T; Hosono O; Iwata S; Ando S; Sasaki K; Nishi T; Kawasaki H; Tanaka H; Morimoto C
    Arthritis Rheum; 2001 Feb; 44(2):296-306. PubMed ID: 11229459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL.
    Martínez-Lorenzo MJ; Anel A; Saez-Gutierrez B; Royo-Cañas M; Bosque A; Alava MA; Piñeiro A; Lasierra P; Asín-Ungría J; Larrad L
    Clin Immunol; 2007 Jan; 122(1):28-40. PubMed ID: 16982214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of T cell apoptosis in the rheumatoid synovium.
    Salmon M; Scheel-Toellner D; Huissoon AP; Pilling D; Shamsadeen N; Hyde H; D'Angeac AD; Bacon PA; Emery P; Akbar AN
    J Clin Invest; 1997 Feb; 99(3):439-46. PubMed ID: 9022077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators' Group.
    Rozman B
    J Rheumatol Suppl; 1998 Jul; 53():27-32. PubMed ID: 9666415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.